Visceral Fat Reduction
Define
Tesamorelin
Select Format
Select Strength
$349 — 1-month supply. Includes your protocol and direct shipping.
✦Want a protocol built around your biology?
Add Precision — lab testing + provider-guided optimization.
Tesamorelin is a GHRH analog that has been studied for visceral adipose tissue reduction.
- ✓Targets visceral fat
- ✓FDA-Approved Active Ingredient
- ✓Subcutaneous injection
- ✓Cardiometabolic support
How It Works
Mimics the body's own GHRH to stimulate pulsatile GH release, which selectively reduces visceral adipose tissue.
Best paired with: Sermorelin, NAD+, CJC-1295
What Happens Next
- 1Complete checkout
- 2Order confirmed
- 3Prepared and shipped from a US facility
Research-use-only products are not subject to provider review — orders are prepared and shipped directly.
Why Researchers Choose Define
- ✓Active ingredient is FDA-approved (Egrifta) — one of the most studied GHRH analogs
- ✓Selectively targets visceral adipose tissue — the metabolically dangerous fat around organs
- ✓Stimulates pulsatile GH release without exogenous hormone replacement
- ✓Supports cardiometabolic markers alongside body composition goals
Intended for research applications in visceral fat and metabolic support.
Complete Your Protocol
Patients often combine Define with these add-ons for enhanced results.
